Objective-Nonadherence to CPAP increases health and functional risks of obstructive sleep apnea. The study purpose was to examine if disease and treatment cognitive perceptions influence short-term CPAP use.Methods-A prospective longitudinal study included 66, middle-aged (56.7 yr ± 10.7) subjects (34 [51.5%] Caucasians; 30 [45.4%] African Americans) with severe OSA (AHI 43.5 events/hr ± 24.6). Following full-night diagnostic/CPAP polysomnograms, home CPAP use was objectively measured at 1 week and 1 month. The Self Efficacy Measure for Sleep Apnea questionnaire (SEMSA), measuring risk perception, outcome expectancies, and self-efficacy, was collected at baseline, post-CPAP education, and after 1 week CPAP treatment. Regression models were used.Results-CPAP use at one week was 3.99 hr/night ± 2.48 and 3.06 hr/night ± 2.43 at one month. No baseline SEMSA domains influenced CPAP use. Post-education self-efficacy influenced one week CPAP use (1.52±0.53, p=0.007). Self-efficacy measured post-education and after one week CPAP use also influenced one month CPAP (1. 40±0.52, p=0.009; 1.20±0.50, p=0.02, respectively). Practice Implications-Patient education is important to OSA patients' formulation of accurate and realistic disease and treatment perceptions which influence CPAP adherence.
Conclusion-CognitiveCorresponding Author: Amy M. Sawyer, Ph.D., R.N., University of Pennsylvania, School of Nursing, Claire M. Fagin Hall, Rm 307b, 418 Curie Blvd, Philadelphia, PA 19104, 215-573-2391, 215-888-2384, asawyer@nursing.upenn.edu. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
NIH-PA Author ManuscriptNIH-PA Author Manuscript
NIH-PA Author ManuscriptStudies that have examined cognitive factors as influential on CPAP use have measured these variables at baseline and after treatment exposure. (20-22) When measured at baseline, these cognitive factors have not been consistently identified as influential on subsequent CPAP use. After 1 week of treatment exposure though, there is evidence to suggest that cognitive perceptions of disease and treatment are influential on both short-(i.e., 1 month) (20) and long-term CPAP use (i.e., 6 months). (21) The primary objective of our study was to determine if disease-specific cognitive perceptions influence CPAP use, specifically examining these factors not only at baseline and after 1 week of CPAP exposure, but also after the delivery of a standardized, disease-and treatment-specific patient education program provided prior to any treatment exposure. We addressed this objective by measuring cognitive perceptions with th...